BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19604349)

  • 1. Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer.
    Mansfield AS; Heikkila PS; Vaara AT; von Smitten KA; Vakkila JM; Leidenius MH
    BMC Cancer; 2009 Jul; 9():231. PubMed ID: 19604349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction.
    Lee JH; Chen Y; Chan JL; Qian YW; Goydos JS
    Cancer Immunol Immunother; 2011 May; 60(5):685-92. PubMed ID: 21327637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients.
    Speeckaert R; Vermaelen K; van Geel N; Autier P; Lambert J; Haspeslagh M; van Gele M; Thielemans K; Neyns B; Roche N; Verbeke N; Deron P; Speeckaert M; Brochez L
    Eur J Cancer; 2012 Sep; 48(13):2004-11. PubMed ID: 22033321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated expression of indoleamine 2, 3-dioxygenase in primary breast cancer correlates with increase of infiltrated regulatory T cells in situ and lymph node metastasis.
    Yu J; Sun J; Wang SE; Li H; Cao S; Cong Y; Liu J; Ren X
    Clin Dev Immunol; 2011; 2011():469135. PubMed ID: 22110525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
    Li F; Zhao Y; Wei L; Li S; Liu J
    Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxP3 and indoleamine 2,3-dioxygenase immunoreactivity in sentinel nodes from melanoma patients.
    Ryan M; Crow J; Kahmke R; Fisher SR; Su Z; Lee WT
    Am J Otolaryngol; 2014; 35(6):689-94. PubMed ID: 25212103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
    J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study.
    Salmi S; Lin A; Hirschovits-Gerz B; Valkonen M; Aaltonen N; Sironen R; Siiskonen H; Pasonen-Seppänen S
    BMC Cancer; 2021 May; 21(1):641. PubMed ID: 34051744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
    Fujii T; Yajima R; Tatsuki H; Kuwano H
    Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
    Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
    Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.
    Dabbs DJ; Fung M; Landsittel D; McManus K; Johnson R
    Breast J; 2004; 10(2):101-5. PubMed ID: 15009035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.
    Shigematsu H; Nishina M; Yasui D; Hirata T; Ozaki S
    World J Surg Oncol; 2019 Feb; 17(1):41. PubMed ID: 30797231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
    Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
    Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival.
    Brody JR; Costantino CL; Berger AC; Sato T; Lisanti MP; Yeo CJ; Emmons RV; Witkiewicz AK
    Cell Cycle; 2009 Jun; 8(12):1930-4. PubMed ID: 19448397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXP3 expression and nodal metastasis of breast cancer.
    Gökmen-Polar Y; Thorat MA; Sojitra P; Saxena R; Badve S
    Cell Oncol (Dordr); 2013 Oct; 36(5):405-9. PubMed ID: 23996727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node (Pilot study).
    Eldweny H; Alkhaldy K; Alsaleh N; Abdulsamad M; Abbas A; Hamad A; Mounib S; Essam T; Kukawski P; Bobin JY; Oteifa M; Amanguono H; Abulhoda F; Usmani S; Elbasmy A
    J Egypt Natl Canc Inst; 2012 Mar; 24(1):23-30. PubMed ID: 23587229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer.
    Nakamura T; Shima T; Saeki A; Hidaka T; Nakashima A; Takikawa O; Saito S
    Cancer Sci; 2007 Jun; 98(6):874-81. PubMed ID: 17433037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.
    Pelosi E; Ala A; Bellò M; Douroukas A; Migliaretti G; Berardengo E; Varetto T; Bussone R; Bisi G
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):937-42. PubMed ID: 15838690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of programmed cell death protein 1 (PD-1) and indoleamine 2,3-dioxygenase (IDO) in the tumor microenvironment and in tumor-draining lymph nodes of breast cancer.
    Ye Q; Wang C; Xian J; Zhang M; Cao Y; Cao Y
    Hum Pathol; 2018 May; 75():81-90. PubMed ID: 29447919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of indoleamine 2,3-dioxygenase and infiltration of FOXP3+ regulatory T cells are associated with aggressive features of papillary thyroid microcarcinoma.
    Ryu HS; Park YS; Park HJ; Chung YR; Yom CK; Ahn SH; Park YJ; Park SH; Park SY
    Thyroid; 2014 Aug; 24(8):1232-40. PubMed ID: 24742251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.